OncoImmune
Dr. Yang Liu, Ph.D. is a founder of OncoImmune, Inc. Dr. Liu also has a part-time position as Director of Division of Immunotherapy, Institute of Human Virology and Professor of Surgery, University of Maryland Baltimore School of Medicine, where his laboratory studies the fundamental mechanisms of immune recognition, cell metabolism and cancer biology and has been a driving force in elucidating the mechanisms by which the innate immune system discriminates microbial infection and aseptic tissue injuries.
This person is not in any offices
OncoImmune
Based in Rockville, Maryland, OncoImmune is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biopharmaceuticals for the treatment of cancer and autoimmune disease.